Cytarabine (Hospira Worldwide, Inc.)
Welcome to the PulseAid listing for the Cytarabine drug offered from Hospira Worldwide, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira Worldwide, Inc. |
| NON-PROPRIETARY NAME: | CYTARABINE |
| SUBSTANCE NAME: | CYTARABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1990-06-04 |
| END MARKETING DATE: | 0000-00-00 |
Cytarabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cytarabine from Hospira Worldwide, Inc. |
| LABELER NAME: | Hospira Worldwide, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 1990-06-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61703-305_4ee12e37-76a7-446a-bcbd-d7dda34b1526 |
| PRODUCT NDC: | 61703-305 |
| APPLICATION NUMBER: | ANDA071868 |
Other CYTARABINE Pharmaceutical Manufacturers / Labelers:
